speb/financial-data huggingface dataset:
FFARM.AS income_statement (annual, 2022-12-31) — Depreciation Income Statement: 35100000.00
FFARM.AS income_statement (annual, 2022-12-31) — Diluted Average Shares: 89805719.00
FFARM.AS income_statement (annual, 2022-12-31) — Diluted EPS: 0.20
FFARM.AS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 18000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 2200000.00
FFARM.AS income_statement (annual, 2022-12-31) — EBIT: 27500000.00
FFARM.AS income_statement (annual, 2022-12-31) — EBITDA: 73000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -3100000.00
FFARM.AS cash_flow (annual, 2022-12-31) — End Cash Position: 26300000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Financing Cash Flow: -17800000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Finished Goods: 19900000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Free Cash Flow: 12900000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -300000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Goodwill: 61400000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 105200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Gross PPE: 669000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Gross Profit: 494800000.00
FFARM.AS income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 2600000.00
FFARM.AS income_statement (annual, 2022-12-31) — Interest Expense: 5300000.00
FFARM.AS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5300000.00
FFARM.AS income_statement (annual, 2022-12-31) — Interest Income: 900000.00
FFARM.AS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 900000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -3500000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Interest Received Cfi: 700000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Inventory: 158200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Invested Capital: 472100000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -34800000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Investment Properties: 600000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 32000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: -200000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 75000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Land And Improvements: 222300000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 23100000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Long Term Debt: 94900000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 118000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 75000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -43000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 32000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Long Term Provisions: 2500000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 306700000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Minority Interest: 9100000.00
FFARM.AS income_statement (annual, 2022-12-31) — Minority Interests: -200000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -3400000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -15600000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Net Debt: 68600000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income: 18000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 18000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 18200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 18000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 18000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 18200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 18200000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -1900000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Interest Income: -5400000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 32000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 32000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -5400000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Net PPE: 311800000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -32400000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 229900000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 2500000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 14200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 16700000.00
FFARM.AS income_statement (annual, 2022-12-31) — Normalized EBITDA: 79800000.00
FFARM.AS income_statement (annual, 2022-12-31) — Normalized Income: 23256400.00
FFARM.AS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 48200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Operating Income: 30400000.00
FFARM.AS income_statement (annual, 2022-12-31) — Operating Revenue: 3315000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 89384795.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 43800000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Other Inventories: 21200000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Other Non Cash Items: 8200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Other Operating Expenses: 242000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Other Properties: 103900000.00
FFARM.AS income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Payables: 450100000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 1000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Pretax Income: 22200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Properties: 0.00
FFARM.AS cash_flow (annual, 2022-12-31) — Purchase Of Business: -3400000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -1900000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Purchase Of PPE: -33400000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Raw Materials: 117100000.00
FFARM.AS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2820200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 45500000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -43000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -15400000.00
FFARM.AS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 300000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Retained Earnings: 18000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
FFARM.AS cash_flow (annual, 2022-12-31) — Sale Of PPE: 1000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 9900000.00
FFARM.AS income_statement (annual, 2022-12-31) — Selling General And Administration: 9900000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Share Issued: 95218821.00
FFARM.AS income_statement (annual, 2022-12-31) — Special Income Charges: -6000000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 600000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 335100000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 229900000.00
FFARM.AS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1543600.00
FFARM.AS income_statement (annual, 2022-12-31) — Tax Provision: 4000000.00
FFARM.AS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
FFARM.AS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 1500000.00
FFARM.AS cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -100000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Assets: 1020400000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Capitalization: 430000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Debt: 166800000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 344200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Total Expenses: 3284600000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 676200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 461300000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 175600000.00
FFARM.AS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 24400000.00
FFARM.AS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 1000000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 200000.00
FFARM.AS income_statement (annual, 2022-12-31) — Total Unusual Items: -6800000.00
FFARM.AS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -6800000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Tradeand Other Payables Non Current: 24200000.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 5834026.00
FFARM.AS balance_sheet (annual, 2022-12-31) — Working Capital: 58500000.00
FFARM.AS income_statement (annual, 2022-12-31) — Write Off: 3400000.00
FFARM.AS income_statement (annual, 2023-12-31) — +Operating Expense: 460200000.00
FFARM.AS income_statement (annual, 2023-12-31) — +Total Revenue: 2974700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Accounts Payable: 349700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 244700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -364500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 143600000.00
FFARM.AS income_statement (annual, 2023-12-31) — Amortization: 9600000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 9600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
FFARM.AS income_statement (annual, 2023-12-31) — Basic Average Shares: 89088776.00
FFARM.AS income_statement (annual, 2023-12-31) — Basic EPS: -0.01
FFARM.AS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 26300000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 15900000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Capital Expenditure: -34400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 40600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Capital Stock: 900000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 46500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 46500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -20500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Cash Equivalents: 0.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Cash Financial: 46500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Change In Inventory: 49700000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Change In Payable: -88700000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Change In Receivables: 82300000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Change In Working Capital: 38000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Changes In Cash: 12400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Common Stock: 900000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -20500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 311500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Common Stock Issuance: -1700000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Common Stock Payments: 0.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Construction In Progress: 16300000.00
FFARM.AS income_statement (annual, 2023-12-31) — Cost Of Revenue: 2497400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Assets: 403200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 8500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Debt: 8000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 16500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Liabilities: 371500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Current Provisions: 3100000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Deferred Tax: -1800000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 0.00
FFARM.AS cash_flow (annual, 2023-12-31) — Depreciation: 34800000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 44400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 44400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Depreciation Income Statement: 34800000.00
FFARM.AS income_statement (annual, 2023-12-31) — Diluted Average Shares: 89088776.00
FFARM.AS income_statement (annual, 2023-12-31) — Diluted EPS: -0.01
FFARM.AS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -1000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 2100000.00
FFARM.AS income_statement (annual, 2023-12-31) — EBIT: 8100000.00
FFARM.AS income_statement (annual, 2023-12-31) — EBITDA: 52500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -200000.00
FFARM.AS cash_flow (annual, 2023-12-31) — End Cash Position: 38500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -66900000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Finished Goods: 13300000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Free Cash Flow: 52100000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -2100000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Goodwill: 55000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 90000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Gross PPE: 668900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Gross Profit: 477300000.00
FFARM.AS income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 13800000.00
FFARM.AS income_statement (annual, 2023-12-31) — Interest Expense: 8000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 8000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Interest Income: 1200000.00
FFARM.AS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 1200000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -7300000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Interest Received Cfi: 900000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Inventory: 108700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Invested Capital: 379400000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -7200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Investment Properties: 600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 36400000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: -1700000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 30000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Land And Improvements: 218200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 32100000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Long Term Debt: 59900000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 92000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 30000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -65000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 36400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Long Term Provisions: 2700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 307900000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Minority Interest: 8900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Minority Interests: -2900000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 20300000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -1700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Net Debt: 21400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income: -1000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -1000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 1900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -1000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -1000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 1900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 1900000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -3000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Interest Income: -8000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -35000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -35000000.00
FFARM.AS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -8000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Net PPE: 304400000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -27500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 221500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 4700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 9600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 16400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Normalized EBITDA: 67700000.00
FFARM.AS income_statement (annual, 2023-12-31) — Normalized Income: 10278400.00
FFARM.AS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 86500000.00
FFARM.AS income_statement (annual, 2023-12-31) — Operating Income: 17100000.00
FFARM.AS income_statement (annual, 2023-12-31) — Operating Revenue: 2974700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 88776454.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 35000000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Other Inventories: 18200000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Other Non Cash Items: 8600000.00
FFARM.AS income_statement (annual, 2023-12-31) — Other Operating Expenses: 236700000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Other Properties: 110600000.00
FFARM.AS income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Payables: 351900000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Pension And Employee Benefit Expense: 1400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Pretax Income: 100000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Properties: 0.00
FFARM.AS cash_flow (annual, 2023-12-31) — Purchase Of Business: -5500000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -3000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Purchase Of PPE: -31400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Raw Materials: 77200000.00
FFARM.AS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2497400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 44400000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -65000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: 0.00
FFARM.AS income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -100000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Retained Earnings: -1000000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Sale Of Business: 25800000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Sale Of PPE: 3900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 7400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Selling General And Administration: 7400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Share Issued: 89283817.00
FFARM.AS income_statement (annual, 2023-12-31) — Special Income Charges: -12400000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 300000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 311500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 221500000.00
FFARM.AS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -3921600.00
FFARM.AS income_statement (annual, 2023-12-31) — Tax Provision: -1800000.00
FFARM.AS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.26
FFARM.AS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 3300000.00
FFARM.AS cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -4200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Assets: 840800000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Capitalization: 371400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Debt: 108500000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 320400000.00
FFARM.AS income_statement (annual, 2023-12-31) — Total Expenses: 2957600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 520400000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 437600000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 148900000.00
FFARM.AS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 4600000.00
FFARM.AS income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 2200000.00
FFARM.AS income_statement (annual, 2023-12-31) — Total Unusual Items: -15200000.00
FFARM.AS income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -15200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Tradeand Other Payables Non Current: 28200000.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 507363.00
FFARM.AS balance_sheet (annual, 2023-12-31) — Working Capital: 31700000.00
FFARM.AS income_statement (annual, 2023-12-31) — Write Off: -1300000.00
FFARM.AS income_statement (annual, 2024-12-31) — +Operating Expense: 462100000.00
FFARM.AS income_statement (annual, 2024-12-31) — +Total Revenue: 2745700000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Accounts Payable: 357600000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 357600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 261300000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 261300000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -364900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -364900000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 143600000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 143600000.00
FFARM.AS income_statement (annual, 2024-12-31) — Amortization: 12600000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 12600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 9400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 9400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Basic Average Shares: 88780976.00
FFARM.AS income_statement (annual, 2024-12-31) — Basic EPS: 0.35
FFARM.AS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 38500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 18500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 18500000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Capital Expenditure: -28200000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 52300000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 52300000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Capital Stock: 900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Capital Stock: 900000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 50700000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 50700000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 50700000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 50700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -14800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Cash Equivalents: 0.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 0.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Cash Financial: 50700000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Cash Financial: 50700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Change In Inventory: -8300000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Change In Payable: -17700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Change In Receivables: 16600000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Change In Working Capital: -14800000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Changes In Cash: -15500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Common Stock: 900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Common Stock: 900000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -14800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 328400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 328400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Common Stock Payments: 0.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Construction In Progress: 9400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 9400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Cost Of Revenue: 2227400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Assets: 450000000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Assets: 450000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 11500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 11500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Debt: 27500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Debt: 27500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 39000000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 39000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Liabilities: 403600000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 403600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Current Provisions: 4200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Current Provisions: 4200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Deferred Tax: 8200000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Defined Pension Benefit: 0.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Defined Pension Benefit: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Depreciation: 38400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 51000000.00
FFARM.AS income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 51000000.00
FFARM.AS income_statement (annual, 2024-12-31) — Depreciation Income Statement: 38400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 36900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 36900000.00
FFARM.AS income_statement (annual, 2024-12-31) — Diluted Average Shares: 88780976.00
FFARM.AS income_statement (annual, 2024-12-31) — Diluted EPS: 0.35
FFARM.AS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 31400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 6800000.00
FFARM.AS income_statement (annual, 2024-12-31) — EBIT: 48700000.00
FFARM.AS income_statement (annual, 2024-12-31) — EBITDA: 99700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — End Cash Position: 23200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Financing Cash Flow: -7400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Finished Goods: 14900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Finished Goods: 14900000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Free Cash Flow: 42000000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 8700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -6000000.00
FFARM.AS income_statement (annual, 2024-12-31) — General And Administrative Expense: 20600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Goodwill: 64000000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Goodwill: 64000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 119200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 119200000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Gross PPE: 693100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Gross PPE: 693100000.00
FFARM.AS income_statement (annual, 2024-12-31) — Gross Profit: 518300000.00
FFARM.AS income_statement (annual, 2024-12-31) — Interest Expense: 6300000.00
FFARM.AS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 6300000.00
FFARM.AS income_statement (annual, 2024-12-31) — Interest Income: 1900000.00
FFARM.AS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1900000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -6700000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Interest Received Cfi: 1500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Inventory: 127100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Inventory: 127100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Invested Capital: 435900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Invested Capital: 435900000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -78300000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Investment Properties: 600000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Investment Properties: 600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Investmentsin Joint Venturesat Cost: 33500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Investmentsin Joint Venturesat Cost: 33500000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 50000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Land And Improvements: 227000000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 227000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 40800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 40800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Long Term Debt: 80000000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 80000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 120800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 120800000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 50000000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -30000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 33500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Long Term Equity Investment: 33500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Long Term Provisions: 3600000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 3600000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 311100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 311100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Minority Interest: 9900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Minority Interest: 9900000.00
FFARM.AS income_statement (annual, 2024-12-31) — Minority Interests: -2800000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -74200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Net Debt: 56800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Net Debt: 56800000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income: 31400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 31400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 34200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 31400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 31400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 34200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 34200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -1400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Interest Income: -7500000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 20000000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 20000000.00
FFARM.AS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -7500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Net PPE: 328200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Net PPE: 328200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -11000000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 209200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 209200000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 9100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 9100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 17700000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 17700000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Normalized EBITDA: 109200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Normalized Income: 39062735.85
FFARM.AS cash_flow (annual, 2024-12-31) — Operating Cash Flow: 70200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Operating Income: 56200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Operating Revenue: 2745700000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 88784800.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 88784800.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 55200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 55200000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Other Inventories: 19100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Other Inventories: 19100000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 3400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Other Operating Expenses: 196900000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Other Properties: 127100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Other Properties: 127100000.00
FFARM.AS income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Payables: 360400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Payables: 360400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Pension And Employee Benefit Expense: 300000.00
FFARM.AS income_statement (annual, 2024-12-31) — Pretax Income: 42400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Properties: 0.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Purchase Of Business: -74200000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -1400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -26800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Raw Materials: 93100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 93100000.00
FFARM.AS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 2227400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 51000000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Repayment Of Debt: -30000000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
FFARM.AS income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Retained Earnings: 31400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 31400000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
FFARM.AS cash_flow (annual, 2024-12-31) — Sale Of PPE: 15800000.00
FFARM.AS income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 7900000.00
FFARM.AS income_statement (annual, 2024-12-31) — Selling General And Administration: 28500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Share Issued: 89283817.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Share Issued: 89283817.00
FFARM.AS income_statement (annual, 2024-12-31) — Special Income Charges: -800000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 1100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 328400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 328400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 209200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 209200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -1837264.15
FFARM.AS income_statement (annual, 2024-12-31) — Tax Provision: 8200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.19
FFARM.AS balance_sheet (annual, 2024-12-31) — Taxes Receivable: 1500000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 1500000.00
FFARM.AS cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -6800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Assets: 942100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Assets: 942100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Capitalization: 408400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 408400000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Debt: 159800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Debt: 159800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 338300000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 338300000.00
FFARM.AS income_statement (annual, 2024-12-31) — Total Expenses: 2689500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 603800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 603800000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 492100000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 492100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 200200000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 200200000.00
FFARM.AS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 55400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Total Other Finance Cost: 3100000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Total Tax Payable: 2800000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 2800000.00
FFARM.AS income_statement (annual, 2024-12-31) — Total Unusual Items: -9500000.00
FFARM.AS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -9500000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Tradeand Other Payables Non Current: 36900000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Tradeand Other Payables Non Current: 36900000.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 499017.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 499017.00
FFARM.AS balance_sheet (annual, 2024-12-31) — Working Capital: 46400000.00
FFARM.AS balance_sheet (quarterly, 2024-12-31) — Working Capital: 46400000.00
FFARM.AS income_statement (annual, 2024-12-31) — Write Off: 800000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 368000000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 291800000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 143600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 3000000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 900000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 61100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 61100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Common Stock: 900000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 327200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Current Assets: 502600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Current Debt: 13900000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 76300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 456500000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Current Provisions: 5000000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 114000000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 415100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Inventory: 145900000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 341100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Investment Properties: 600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Investmentsin Joint Venturesat Cost: 1300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 95300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 1300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 12300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Minority Interest: 79100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Net PPE: 415100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 213200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 8500000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 18900000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 20100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 88384800.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Other Properties: 415100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Payables: 375200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 23600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Share Issued: 89283817.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 327200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 213200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 800000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Assets: 1049400000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 327200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Debt: 171600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 406300000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 643100000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 546800000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 186600000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 7200000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Tradeand Other Payables Non Current: 40000000.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 899017.00
FFARM.AS balance_sheet (quarterly, 2025-06-30) — Working Capital: 46100000.00
FFARM.AS income_statement (annual, 2025-12-31) — +Operating Expense: 526600000.00
FFARM.AS income_statement (annual, 2025-12-31) — +Total Revenue: 3153100000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Accounts Payable: 388800000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 388800000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 277300000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 277300000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -374300000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -374300000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 143600000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 143600000.00
FFARM.AS income_statement (annual, 2025-12-31) — Amortization: 12700000.00
FFARM.AS cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 12700000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 0.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 0.00
FFARM.AS income_statement (annual, 2025-12-31) — Basic Average Shares: 88625286.00
FFARM.AS income_statement (annual, 2025-12-31) — Basic EPS: 0.56
FFARM.AS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 23200000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 24300000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 24300000.00
FFARM.AS cash_flow (annual, 2025-12-31) — Capital Expenditure: -51700000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 69900000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 69900000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Capital Stock: 900000.00
FFARM.AS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 900000.00
FFARM.AS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 109700000.00